Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Proffered Abstracts - Poster Presentations

Abstract 31: The association between GWAS SNPs and mammographic density in Norwegian postmenopausal women stratified by nongenetic factors.

Merete Ellingjord-Dale, Isabel dos Santos Silva, Eunjung Lee, Elisabeth Couto, David Van Den Berg, Solveig Hofvind, Tom Grotmol and Giske Ursin
Merete Ellingjord-Dale
1University of Oslo, Oslo, Norway, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Southern California, Los Angeles, CA, 4Cancer Registry of Norway, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel dos Santos Silva
1University of Oslo, Oslo, Norway, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Southern California, Los Angeles, CA, 4Cancer Registry of Norway, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eunjung Lee
1University of Oslo, Oslo, Norway, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Southern California, Los Angeles, CA, 4Cancer Registry of Norway, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Couto
1University of Oslo, Oslo, Norway, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Southern California, Los Angeles, CA, 4Cancer Registry of Norway, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Van Den Berg
1University of Oslo, Oslo, Norway, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Southern California, Los Angeles, CA, 4Cancer Registry of Norway, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Solveig Hofvind
1University of Oslo, Oslo, Norway, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Southern California, Los Angeles, CA, 4Cancer Registry of Norway, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Grotmol
1University of Oslo, Oslo, Norway, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Southern California, Los Angeles, CA, 4Cancer Registry of Norway, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giske Ursin
1University of Oslo, Oslo, Norway, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Southern California, Los Angeles, CA, 4Cancer Registry of Norway, Oslo, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.GWAS-31 Published November 2012
  • Article
  • Info & Metrics
Loading

Abstract

Background: Mammographic density (MD) is one of the strongest known breast cancer risk factors. Dense breast tissue is characterized by increased stromal tissue and possibly by increased numbers of breast epithelial cells. Twin studies have suggested that part of the variation in MD is determined by genetic factors, however, it is also clear that non-genetic factors such as hormone use, body weight and reproductive factors play a role. Exactly which genetic factors determine MD is not clear, although several genome-wide association studies (GWAS) conducted over the past few years have suggested a number of variants. We hypothesized that the effect of genetic variants on MD may be strongly modified by non-genetic factors. We therefore evaluated the association between percent MD and 17 single nucleotide polymorphisms (SNPs) identified from several published GWAS of MD/breast cancer by strata defined by non-genetic factors.

Methods: We assessed MD on 2036 postmenopausal women aged 50-69 years who participated in the Norwegian Breast Cancer Screening Program (NBCSP) in 2004 using a computer assisted method (Madena, University of Southern California). We used linear regression (additive model) to determine the association between each SNP and MD, adjusting for age and body mass index (BMI). The postmenopausal women were stratified on postmenopausal hormone therapy (HT) use, parity, BMI, and alcohol intake.

Results: In all postmenopausal women a variant (rs29815829) in the FGFR2 gene and a variant (rs3734805) in the 6q25.1 gene associated significantly with MD (regression coefficient (beta)=-1.42, p=0.0306 and beta=0.74, p=0.0390). The same variants showed significant associations in never HT users with slightly stronger effect estimates, but not in current combined estrogen and progestin therapy users.

We also observed some possible effect modification by parity. In all postmenopausal parous women as well as in parous never HT users, the 6q25.1 and the FGFR2 variants were the most important (lowest p-values). However, in nulliparous never HT users a variant (rs3803662) in the TOX3 gene and a variant (rs1045485) in the CASP8 gene associated significantly with MD (beta=1.41, p=0.0120 and beta= 1.42, p=0.0275). There were no apparent differences between alcohol drinkers or non-drinkers in never HT users, regardless of parity. When examining strata of BMI among never HT users, we found a significant association with MD in the CASP8 gene (rs1746827) in women with a BMI < 25 (beta=0.81, p=0.0507) and in the FGFR2 gene (rs2981582) in women with a BMI >25 <29 (beta=-2.34; p=0.0284).

Conclusion: We found some evidence that the associations between variants in the 6q25.1 gene and in the FGFR2 gene and MD were modified by HT use. Further, our results suggest that the genetic determinants of MD may differ between parous and nulliparous women, and across BMI strata.

Citation Format: Merete Ellingjord-Dale, Isabel dos Santos Silva, Eunjung Lee, Elisabeth Couto, David Van Den Berg, Solveig Hofvind, Tom Grotmol, Giske Ursin. The association between GWAS SNPs and mammographic density in Norwegian postmenopausal women stratified by nongenetic factors. [abstract]. In: Proceedings of the AACR Special Conference on Post-GWAS Horizons in Molecular Epidemiology: Digging Deeper into the Environment; 2012 Nov 11-14; Hollywood, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2012;21(11 Suppl):Abstract nr 31.

  • ©2012 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 21 (11 Supplement)
November 2012
Volume 21, Issue 11 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 31: The association between GWAS SNPs and mammographic density in Norwegian postmenopausal women stratified by nongenetic factors.
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract 31: The association between GWAS SNPs and mammographic density in Norwegian postmenopausal women stratified by nongenetic factors.
Merete Ellingjord-Dale, Isabel dos Santos Silva, Eunjung Lee, Elisabeth Couto, David Van Den Berg, Solveig Hofvind, Tom Grotmol and Giske Ursin
Cancer Epidemiol Biomarkers Prev November 1 2012 (21) (11 Supplement) 31; DOI: 10.1158/1055-9965.GWAS-31

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 31: The association between GWAS SNPs and mammographic density in Norwegian postmenopausal women stratified by nongenetic factors.
Merete Ellingjord-Dale, Isabel dos Santos Silva, Eunjung Lee, Elisabeth Couto, David Van Den Berg, Solveig Hofvind, Tom Grotmol and Giske Ursin
Cancer Epidemiol Biomarkers Prev November 1 2012 (21) (11 Supplement) 31; DOI: 10.1158/1055-9965.GWAS-31
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Proffered Abstracts - Poster Presentations

  • Abstract 79: The relationship between abdominal fat distribution, vitamin D levels, and physical activity in colorectal cancer patients: A pilot study.
  • Abstract 81: Dietary supplement use among German colorectal cancer patients: The ColoCare Study.
  • Abstract 82: Gene expression induced by acrylamide and glycidamide in mammalian cells.
Show more Proffered Abstracts - Poster Presentations

Molecular Epidemiology and Gene-Environment Interactions

  • Abstract PR2: Pathway-based gene-environment interactions in ovarian cancer.
  • Abstract PR6: Genetically determined differences in arsenic metabolism efficiency influence risk for premalignant skin lesions in Bangladesh: Mendelian randomization and gene-environment interaction.
  • Abstract PR1: LINE-1 %5-methyl cytosine levels in prediagnostic leukocyte DNA and future bladder cancer risk among PLCO and ATBC cohort subjects.
Show more Molecular Epidemiology and Gene-Environment Interactions
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement